Colorectal Cancer

Colorectal cancer screening rates among underserved populations increased among patients who received at-home fecal immunochemical tests, according to study results.

People who ordered a colorectal cancer screening kit through a patient portal were nearly four times more likely to complete it than those who received a kit automatically in the mail, a retrospective observational study showed.

Although colorectal cancer mortality has declined steadily since the 1940s, the long-term prognosis for patients with late-stage metastatic disease has remained relatively poor.

Long-term, regular use of aspirin before diagnosis appeared associated with lower colorectal cancer-specific mortality, according to results of an observational study published in Journal of the National Cancer Institute.

Individuals with obesity and high alcohol consumption, as well as other factors, were at higher risk for developing early-onset colorectal cancer, according to study results.

Delayed colonoscopy after an abnormal stool-based screening test was associated with increased risk for colorectal cancer, according to study results.

Population-based fecal immunochemical test screening was effective at reducing risk for advanced colorectal cancer and associated mortality, according to study results.

The organization Fight Colorectal Cancer is celebrating that the Removing Barriers to Colorectal Cancer Screening Act has been recently signed into law.

A recent study presented at the Gastrointestinal Cancers Symposium revealed low health-related quality of life scores among young adult survivors of colorectal cancer. It was the top story in hematology/oncology last week.

Pembrolizumab monotherapy demonstrated superior PFS and PFS2 compared with standard-of-care chemotherapy among patients with microsatellite-instability high/mismatch repair-deficient metastatic colorectal cancer.